Peripheral blood samples from patients with varying degrees of AD were analyzed to measure the percentage of CD4+CD25+CD127low/- Tregs via flow cytometry, as well as the levels of IL-10, IL-35, and TGF-beta via ELISA [98]. This evidence concerns the gene IL2RA and Alzheimer disease.